Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

CPG-10101 improves responses in relapsed hepatitis C treatment responders

May 25, 2006

Early studies with alpha4 integrin antagonist T-728 suggest possible use in IBD

May 24, 2006

J&J develops novel leukotriene A4 hydrolase inhibitors for IBD

May 24, 2006

Tranzyme presents new in vivo data on novel gastrointestinal drug candidates

May 24, 2006

XP-19986 reduces number of reflux episodes in GERD patients

May 24, 2006

Studies examine celgosivir pharmacokinetics, activity and tolerability

May 24, 2006

Pooled data allow subgroup analysis of lubiprostone efficacy in constipation

May 24, 2006

Telbivudine superior to adefovir in chronic hepatitis B

May 24, 2006

Intestinal inflammation may be reduced with cannabinoid receptor 2 agonists

May 23, 2006

The alpha7 nicotinic agonist AR-R17779 shows efficacy in a rat model of postoperative ileus

May 23, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...